Skip to main content

Clinical Trial Modernization Act (H.R. 3521)

Referred to Committee
Introduced 5/20/2025•119th Congress•House

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

5/20/2025 • House

Summary

Clinical Trial Modernization Act

This bill authorizes a grant program and provides certain exemptions to support the participation of individuals in clinical trials.

Specifically, the bill authorizes a grant program to support outreach, education, and recruitment efforts for clinical trials that may benefit certain underrepresented populations or communities in need, such as rural or tribal areas.

The bill also exempts from anti-kickback laws for federal health care programs (1) remuneration that is offered to cover participants' expenses to participate in clinical trials, (2) the provision of free digital health technologies to support participation of underrepresented populations in clinical trials, and (3) payment for participants' cost-sharing obligations in relation to clinical trials.

Finally, the bill exempts up to $2,000 in remuneration that is received for participating in a clinical trial from income tax.

Introduced in House • 5/20/2025

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (34)

Party Breakdown

22
Democrats
12
Republicans
0
Independents

Sponsor

R[
Rep. Ruiz, Raul [D-CA-25]

Democrat • CA-25

Sponsored 5/20/2025

Cosponsors (33)

R[
Rep. Pfluger, August [R-TX-11]

R-TX-11

Joined 5/20/2025

R[
Rep. Ciscomani, Juan [R-AZ-6]

R-AZ-6

Joined 6/4/2025

R[
Rep. Cohen, Steve [D-TN-9]

D-TN-9

Joined 6/11/2025

R[
Rep. Soto, Darren [D-FL-9]

D-FL-9

Joined 7/10/2025

R[
Rep. Auchincloss, Jake [D-MA-4]

D-MA-4

Joined 9/2/2025

R[
Rep. Lynch, Stephen F. [D-MA-8]

D-MA-8

Joined 8/20/2026

Bill Journey

Originated in the House

Introduced

May 20, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House5/20/2025

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors33

Sources and method

· Record updated Nov 6, 2026
  • Congress.govLibrary of Congress
    Status, actions, sponsors, cosponsors, committees and text
    Record updated Nov 6, 2026 · Loaded Nov 6, 2026, 6:28 AM ET
  • CRS bill summaryCongressional Research Service, via Congress.gov
    Official summary
    Summary of the “Introduced in House” version, May 20, 2025 · Loaded Nov 6, 2026, 6:28 AM ET
  • USAspending.govU.S. Department of the Treasury
    Related Federal Spending section
  • FEC filingsFederal Election Commission
    Funding & Lobbying section
  • Lobbying disclosures (LDA)Secretary of the Senate and Clerk of the House
    Funding & Lobbying section

All sources: Public domain (17 U.S.C. § 105) · Method: Data sources → · Campaign finance →

AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →

Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.